A detailed history of Exodus Point Capital Management, LP transactions in Insmed Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 85,183 shares of INSM stock, worth $6.07 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
85,183
Previous 25,000 240.73%
Holding current value
$6.07 Million
Previous $1.67 Million 271.89%
% of portfolio
0.04%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$62.0 - $79.01 $2.64 Million - $3.36 Million
42,578 Added 99.94%
85,183 $6.22 Million
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $937,310 - $2.97 Million
42,605 New
42,605 $2.86 Million
Q3 2023

Nov 09, 2023

BUY
$19.86 - $26.93 $658,656 - $893,133
33,165 New
33,165 $837,000
Q4 2022

Feb 13, 2023

SELL
$16.98 - $23.15 $2.6 Million - $3.55 Million
-153,307 Reduced 67.08%
75,227 $1.5 Million
Q3 2022

Nov 10, 2022

BUY
$20.88 - $28.21 $4.45 Million - $6.01 Million
213,093 Added 1380.05%
228,534 $4.92 Million
Q2 2022

Aug 19, 2022

BUY
$17.07 - $25.71 $263,577 - $396,988
15,441 New
15,441 $304,000
Q2 2021

Aug 16, 2021

SELL
$24.17 - $36.01 $1.62 Million - $2.41 Million
-67,008 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$32.28 - $44.3 $119,113 - $163,467
3,690 Added 5.83%
67,008 $2.28 Million
Q4 2020

Feb 16, 2021

BUY
$31.45 - $40.54 $1.73 Million - $2.24 Million
55,132 Added 673.49%
63,318 $2.11 Million
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $148,980 - $197,685
-5,730 Reduced 41.18%
8,186 $263,000
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $196,354 - $409,408
13,916 New
13,916 $383,000
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $328,101 - $817,966
-24,072 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $33,948 - $52,607
2,106 Added 9.59%
24,072 $575,000
Q3 2019

Nov 14, 2019

BUY
$15.49 - $25.78 $340,253 - $566,283
21,966 New
21,966 $387,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.